<DOC>
	<DOCNO>NCT01575379</DOCNO>
	<brief_summary>Recent evidence epidemiological study suggest serum uric acid level higher average predispose diabetic patient kidney damage . The purpose study gather preliminary information whether lower serum uric acid mean oral allopurinol ( drug commonly use treatment gout ) use prevent delay loss kidney function may accompany diabetes . The result study help u design large study find whether medication prevent kidney problem , particular loss kidney function , people type 1 diabetes .</brief_summary>
	<brief_title>A Pilot Study Allopurinol Prevent Kidney Function Loss Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<criteria>Male female T1D patient 18 60 year age . T1D diagnose age 35 continuously treated insulin within one year diagnosis . If onset age 31 35 , body mass index ( BMI ) require &lt; 26 kg/m2 time diagnosis ; Duration T1D ≥ 5 year ; Presence microalbuminuria moderate macroalbuminuria ( least two three consecutive urinary albumin excretion rate [ AER ] urinary albumin/creatinine ratio ( ACR ) measure precede two year 301500 mg/24 hr 301500 mg/g range , respectively ) . Estimated GFR ( base serum creatinine CKDEPI equation ) 35 109 ml/min/1.73 m2 screen visit . Measured GFR 45 99 ml/min/1.73 m2 end runin period ; Serum UA ≥ 4.5 mg/dl screen visit . Willing comply schedule event protocol requirement . History gout require uric acid lower therapy xanthinuria indication uric acid lower therapy cancer chemotherapy extremely high serum uric acid value ( ≥12 mg/dl ) Recurrent renal calculus . Use uratelowering agent within 3 month enrollment . Current use azathioprine , 6mercaptopurine , didanosine , warfarin , tamoxifen , amoxicillin/ampicillin , drug interact allopurinol . Known allergy xanthineoxidase inhibitor iodine contain substance . HLA B*58:01 genotype ( determined time randomization ) indicating increase risk StevensJohnson syndrome response allopurinol . Renal transplant . Nondiabetic kidney disease indicate medical history and/or laboratory finding . SBP &gt; 160 DBP &gt; 100 mmHg screen SBP &gt; 140 DBP &gt; 90 mmHg end runin period . Cancer treatment within two year enrollment . History clinically significant hepatic disease include hepatitis B C and/or ALT ( SGPT ) &gt; 2.50 x ULN screening ; History acquire immune deficiency syndrome human immunodeficiency virus ( HIV ) ; Hemoglobin concentration &lt; 11 g/dL ( male ) , &lt; 10 g/dL ( female ) screen . Platelet count &lt; 100,000/mm3 screening . History alcohol drug abuse past 12 month Breastfeeding pregnancy unwillingness contraception . Poor mental function reason expect patient difficulty comply requirement study . Serious preexist medical problem diabetes , e.g . congestive heart failure , pulmonary insufficiency .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>allopurinol</keyword>
	<keyword>uric acid</keyword>
	<keyword>diabetes</keyword>
	<keyword>nephropathy</keyword>
</DOC>